NASDAQ
Cadrenal Therapeutics, Inc. Common Stock (CVKD) has a current ratio of 2.72x as of Monday, May 25, 2026. This represents a 44.04% decrease compared to its 12-month average of 4.86x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.